| Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 Diabetes (NCT00474045) | Novo Nordisk A/S | 2007-05-01 |
| Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy (NCT00476931) | Sangamo Therapeutics | 2007-05-01 |
| Evaluation of Levemir® for the Treatment of Type 1 and 2 Diabetes (NCT00655044) | Novo Nordisk A/S | 2007-05-01 |
| Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes (NCT00665093) | Novo Nordisk A/S | 2007-05-01 |
| Gulf, Lantus, Apidra Evaluation in Type 1 Diabetics Study (NCT00539448) | Sanofi | 2007-04-01 |
| A Study for Patients With Type 1 Diabetes Mellitus (NCT00447213) | Eli Lilly and Company | 2007-04-01 |
| Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 Diabetes (NCT00447382) | Novo Nordisk A/S | 2007-03-01 |
| Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes (NCT00435019) | Novo Nordisk A/S | 2007-02-01 |
| Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus (NCT00419562) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2007-02-01 |
| UVA Islet Cell Transplantation in Patients With Type I Diabetes (NCT00605592) | University of Virginia | 2007-01-01 |
| A Study for Patients With Diabetes Mellitus (IOPA) (NCT00420095) | Eli Lilly and Company | 2007-01-01 |
| Correlation of Flicker Induced and Flow Mediated Vasodilatation in Patients With Endothelial Dysfunction and Healthy Volunteers. (NCT00432029) | Medical University of Vienna | 2006-12-01 |
| A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog® (NCT00356421) | Pfizer | 2006-11-01 |
| Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy (NCT00406458) | Sangamo Therapeutics | 2006-11-01 |
| Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes (NCT00434850) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-10-01 |
| Evaluation of Safety and Parameters of Application Technique (NCT01516242) | Novo Nordisk A/S | 2006-10-01 |
| Observational Study of the Predictability of Levemir® in Terms of Metabolic Control, Change of Body Weight and Hypos (NCT01542489) | Novo Nordisk A/S | 2006-10-01 |
| Long-term Function of Beta Cell Allografts in Non-uremic Type 1 Diabetic Patients (NCT00798785) | Universitair Ziekenhuis Brussel | 2006-10-01 |
| Vascular Reactivity in Kidney Disease Patients (NCT00226902) | Melbourne Health | 2006-09-01 |
| Comparison of Explorative Formulation of Insulin Degludec and Insulin Aspart Co-formulation Versus Explorative Formulation of Insulin Degludec and Insulin Aspart Separately Compared With Biphasic Insulin Aspart 30 in Male Subjects With Diabetes (NCT01865305) | Novo Nordisk A/S | 2006-09-01 |
| Investigation of Pharmacodynamic Characteristics of Explorative Formulation of Insulin Degludec in Male Subjects With Type 1 Diabetes (NCT01865318) | Novo Nordisk A/S | 2006-09-01 |
| Comparing the Pharmacodynamics and Pharmacokinetics of Explorative Formulation of Insulin Degludec With Insulin Glargine in Subjects With Type 1 and Type 2 Diabetes (NCT01865292) | Novo Nordisk A/S | 2006-08-01 |
| Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes (NCT00356109) | Eli Lilly and Company | 2006-08-01 |
| The Impact of Initiating/Switching to Insulin Detemir on Emotional Well-being and Treatment Satisfaction (NCT01542476) | Novo Nordisk A/S | 2006-08-01 |
| TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM) (NCT00451321) | GlaxoSmithKline | 2006-07-31 |
| The Effect of Hyperglycaemia on Local Energy Stores in the Working Muscle in Patients With Type 1 Diabetes Mellitus (NCT00325559) | Insel Gruppe AG, University Hospital Bern | 2006-06-01 |
| Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma (NCT00332826) | Mannkind Corporation | 2006-06-01 |
| Comparison of NovoFine® Needles (4 mm vs. 6 mm) (NCT00343343) | Novo Nordisk A/S | 2006-06-01 |
| Glucagon Modulation of Ghrelin Secretion (NCT00929812) | Charite University, Berlin, Germany | 2006-06-01 |
| Observational Study to Evaluate the Safety of Levemir® in Patients With Diabetes (NCT01545791) | Novo Nordisk A/S | 2006-05-01 |
| The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes: A Comparison of 3 Long-acting Insulins (NCT00313742) | Novo Nordisk A/S | 2006-04-01 |
| Diabetes Technology Study of Real-Time Glucose Alerts in the Team Management of Diabetes (NCT00322478) | Diabetech | 2006-04-01 |
| Blood Glucose Awareness Training for Parents (NCT00315991) | University of Virginia | 2006-04-01 |
| Comparison of the Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 and Insulin Aspart in Subjects With Type 1 Diabetes (NCT01536028) | Novo Nordisk A/S | 2006-04-01 |
| Renal and Peripheral Hemodynamic Function in Patients With Type 1 Diabetes Mellitus (NCT00297401) | Chromaderm, Inc. | 2006-03-01 |
| An Observational Study in Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes Mellitus (NCT01542424) | Novo Nordisk A/S | 2006-03-01 |
| Effects of Aspirin Treatment on Fibrin Network Formation in Patients With Type 1 Diabetes (NCT01397513) | Karolinska Institutet | 2006-03-01 |
| Telemetric Glucose Data Acquisition During Initiation of Insulin Pump Therapy (NCT00297635) | Thomas Jefferson University | 2006-03-01 |
| Study to Compare Intraperitoneal Insulin to Subcutaneous Insulin Administration in Type 1 Diabetes Mellitus (NCT00286962) | Medical Research Foundation, The Netherlands | 2006-02-01 |
| Counter-Regulatory Impairment and the Effect of Microvascular Insulin Transfer in Type 1 Diabetes Mellitus (NCT00943787) | University of Virginia | 2006-01-01 |
| Efficacy and Safety of Levemir® Used as Basal Insulin (NCT01548248) | Novo Nordisk A/S | 2006-01-01 |
| Comparison of Basal (Fasting) Glycemic Control in Type 1 Diabetic Patients With CSII Achieved by the Circadian Slide Ruler Scale or Flat Basal Rate (NCT00569452) | Hoffmann-La Roche | 2006-01-01 |
| Improving Control and Reducing the Risk of Hypoglycemic Episodes in Type 1 Diabetes (NCT00315939) | Boris Kovatchev, PhD | 2006-01-01 |
| Family Management of Type 1 Diabetes in Children (NCT00273286) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2006-01-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Explorative Formulation of Insulin Degludec (NCT01865279) | Novo Nordisk A/S | 2005-12-01 |
| Safety and Efficacy of PEG-Encapsulated Islet Allografts Implanted in Type I Diabetic Recipients (NCT00260234) | Novocell | 2005-11-01 |
| Cholesterol and Fatty Acid Synthesis in Islet and Liver Transplant Patients and Effect of Dietary Intervention (NCT00947635) | University of Alberta | 2005-11-01 |
| Safety of Insulin Detemir for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus (NCT01709929) | Novo Nordisk A/S | 2005-10-01 |
| Efficacy Study on the Control of Blood Glucose Concentration in Type 1 Diabetic Patients (NCT00271284) | Sanofi | 2005-10-01 |
| Effect of Exercise on the Absorption of Inhaled Human Insulin in Subjects With Type 1 Diabetes (NCT00419718) | Novo Nordisk A/S | 2005-10-01 |
| Basal Analog Study - Comparison of Lantus or Levemir With NPH Insulin From T1DM Diagnosis (NCT01271517) | Karolinska Institutet | 2005-09-01 |
| Prospective Study on Diabetes Mellitus and Its Complications in Newly Diagnosed Adult Patients (NCT01055093) | German Diabetes Center | 2005-09-01 |
| Diabetes Telemedicine Consultation: A Systems Improvement Intervention (NCT00119041) | US Department of Veterans Affairs | 2005-09-01 |
| Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes (NCT00129259) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-09-01 |
| NovoLet® Acceptance Study Within the Hospital Practise in Indonesia (NCT01492205) | Novo Nordisk A/S | 2005-09-01 |
| APIDRA Registration Study (NCT00489190) | Sanofi | 2005-08-01 |
| Effects of Vitamin B1 in Type 1 Diabetic Patients (NCT00117026) | University Hospital, Aker | 2005-08-01 |
| Influence of Binge Drinking on Glucose Metabolism in Patients With Type 1 Diabetes - A Pilot Study (NCT00135915) | The Royal Bournemouth Hospital | 2005-08-01 |
| Effect of Medium Chain Fatty Acids on Cognitive Function During Acute Hypoglycemia in Patients With Type 1 Diabetes (NCT00592072) | Yale University | 2005-07-01 |
| Type 1 Diabetes Aerobic and Resistance Exercise (T1-DARE) (NCT00148538) | Ottawa Hospital Research Institute | 2005-07-01 |
| Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes (NCT00127634) | Eli Lilly and Company | 2005-07-01 |
| Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 Diabetes (NCT00117780) | Novo Nordisk A/S | 2005-06-01 |
| Retinal Function in Diabetic Patients Without Retinopathy (NCT00839150) | Assistance Publique - Hôpitaux de Paris | 2005-05-01 |
| Type 1 Diabetes Recurrence in Pancreas Transplants (NCT01047865) | University of Miami | 2005-05-01 |
| Improving Blood Pressure Management in Patients With Diabetes (NCT00374270) | University of Alberta | 2005-05-01 |
| Within-subject Variability of Insulin Detemir in Children and Adolescents With Type 1 Diabetes (NCT01497574) | Novo Nordisk A/S | 2005-05-01 |
| Evaluating the Use of Two Different Needles in Subjects With Diabetes (NCT00569426) | Novo Nordisk A/S | 2005-04-01 |
| A 3 Month, Randomized, Open Label, Multi-center Study of Technosphere/Insulin Compared to Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Receiving Insulin Glargine (NCT00539396) | Mannkind Corporation | 2005-03-01 |
| Local Registration Trial in China Humalog Mix 50 (NCT00191581) | Eli Lilly and Company | 2005-03-01 |
| Efficacy of Diazoxide in Type 1 Diabetes (NCT00131755) | Grill, Valdemar, M.D. | 2005-02-01 |
| Outcomes and Cost Consequences of Using an Internet Co-Management Module to Improve the Quality of Type 1 Diabetes Care (NCT00194558) | University of Washington | 2005-02-01 |
| Insulin Glulisine, Diabetes Mellitus Type 1 (NCT00397553) | Sanofi | 2005-01-01 |
| Surveillance Study of NovoRapid® for New Drug Re-examination (NCT01490112) | Novo Nordisk A/S | 2005-01-01 |
| To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin. (NCT00143104) | Pfizer | 2004-12-01 |
| Efficacy and Safety of Insulin Glulisine in Type 1 Diabetes Mellitus (NCT00290979) | Sanofi | 2004-12-01 |
| Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression (NCT00566813) | University of Illinois at Chicago | 2004-11-01 |
| Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents (NCT00097071) | Novo Nordisk A/S | 2004-10-01 |
| Eye on Diabetes: A Multidisciplinary Patient Education Intervention (NCT00417924) | Nova Southeastern University | 2004-10-01 |
| Metabolic Effects of Accurate Blood Sugar Results and Education in Type 1 Diabetes (NCT00284232) | Helse Stavanger HF | 2004-10-01 |
| Glulisine + Lantus in Type I Patients (NCT00546702) | Sanofi | 2004-09-01 |
| Evaluation of the Use of Levemir® in Insufficiently Controlled Patients With Type 1 or Type 2 Diabetes (NCT01542463) | Novo Nordisk A/S | 2004-09-01 |
| Glulisine + Lantus in Type I Patients (NCT00545337) | Sanofi | 2004-09-01 |
| Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 Diabetes (NCT00095082) | Novo Nordisk A/S | 2004-09-01 |
| Post Marketing Surveillance Study of Biphasic Insulin Aspart 30 (NCT01536613) | Novo Nordisk A/S | 2004-09-01 |
| Comparison of Insulin Detemir and Insulin Semilente®MC in Type 1 Diabetes (NCT00184639) | Novo Nordisk A/S | 2004-08-16 |
| Pilot Study on the Effect of Oral Controlled-Release Alpha-Lipoic Acid on Oxidative Stress in Adolescents With Type 1 Diabetes Mellitus (NCT00187564) | University of California, San Francisco | 2004-08-01 |
| Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 Diabetes (NCT00593255) | Novo Nordisk A/S | 2004-07-01 |
| NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes (NCT00095446) | Novo Nordisk A/S | 2004-07-01 |
| Observational Study to Evaluate the Safety of Levemir® in Diabetes (NCT00659295) | Novo Nordisk A/S | 2004-06-01 |
| Comparison of Insulin Detemir With NPH Insulin in Type 1 Diabetes (NCT00184665) | Novo Nordisk A/S | 2004-06-01 |
| Safety of Insulin Detemir in Children With Type 1 Diabetes (NCT00605137) | Novo Nordisk A/S | 2004-05-21 |
| New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial (NCT00100178) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2004-05-01 |
| Comparison of Insulin Detemir and NPH With Respect to Lowering the Blood Sugar and Symptoms Experienced by Type 1 Diabetics During Hypoglycaemia (NCT00760448) | Novo Nordisk A/S | 2004-04-01 |
| Observational Study With InnoLet® in Daily Clinical Practice (NCT01492959) | Novo Nordisk A/S | 2004-03-23 |
| Cadaveric Islet Transplantation in Patients With Insulin-Dependent Diabetes Mellitus (NCT00579371) | University of Nebraska | 2004-03-17 |
| Observational Study With Mixtard® 30 NovoLet® to Assess Patient Satisfaction (NCT01492218) | Novo Nordisk A/S | 2004-03-15 |
| TrialNet Pathway to Prevention of T1D (NCT00097292) | University of South Florida | 2004-02-01 |
| Sirolimus vs Mycophenolate With Tacrolimus in Simultaneous Pancreas and Kidney Transplantation (NCT03582878) | Institute for Clinical and Experimental Medicine | 2004-01-01 |
| Efficacy and Safety of Insulin Detemir in Type 1 Diabetes (NCT00595374) | Novo Nordisk A/S | 2003-12-02 |
| Special Survey for Patients With Type 1 or Type 2 Diabetes (NCT01538589) | Novo Nordisk A/S | 2003-12-01 |